(Total Views: 87)
Posted On: 05/28/2025 7:09:14 AM
Post# of 96
The AMA says YES to OGM. The FDA says NO.
It certainly seems that way. Optical Genome Mapping (OGM) has demonstrated undeniable clinical value, yet regulatory approval remains elusive. Despite major institutions like Johns Hopkins and MD Anderson validating its effectiveness, the FDA’s prolonged silence raises concerns about whether patient-centered innovation is being overshadowed by bureaucratic and financial influences.
Big money’s got its boot on OGM’s neck!
It certainly seems that way. Optical Genome Mapping (OGM) has demonstrated undeniable clinical value, yet regulatory approval remains elusive. Despite major institutions like Johns Hopkins and MD Anderson validating its effectiveness, the FDA’s prolonged silence raises concerns about whether patient-centered innovation is being overshadowed by bureaucratic and financial influences.
Big money’s got its boot on OGM’s neck!
(1)
(0)
